JVC-26996-26526
3 vaccinations
5 coded responses
30 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 190 / PA
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- NZX-25206-73116
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-06-24
Dose 1 — Pfizer-BioNTech
- 2022-06-25
- 2022-06-26
-
2022-06-27
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Rhinorrhoea, Sneezing — Feeling: Poor · Irritability/crying · Be unable to do your normal daily activitiesFree text: Sneezy and snottyMedDRA releases: 2024-11 · check-in free text available
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-08
-
2022-07-15
Dose 2 — Pfizer-BioNTech
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-29
- 2022-08-05
-
2022-08-12
Survey response — day 28, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough congestion sneezing cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-08-19
-
2022-08-26
Survey response — day 42, dose 2, under 3MedDRA: Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FeverMedDRA releases: 2024-11 · check-in free text available
-
2022-09-09
Dose 3 — Pfizer-BioNTech
-
2022-09-11
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Sneezing — Feeling: FairFree text: SneezyMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-09-16
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Pfizer-BioNTech | No |
| 2 | 2022-07-15 | Pfizer-BioNTech | No |
| 3 | 2022-09-09 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Sneezy and snotty
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Cough congestion sneezing cold symptoms
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Fever
Release 12 (Under 3) — days 1–6 daily, dose 3, under 3
Systemic reaction (other): Sneezy
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release